Found: 49
Select item for more details and to access through your institution.
Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
- By:
- Publication type:
- Article
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1032397
- By:
- Publication type:
- Article
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1033871
- By:
- Publication type:
- Article
SIRPα Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.904718
- By:
- Publication type:
- Article
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
- By:
- Publication type:
- Article
Real‐world analysis of safety and efficacy of CAR T‐cell therapy in lymphoma patients with decreased kidney function.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. e11, doi. 10.1111/bjh.19152
- By:
- Publication type:
- Article
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. 738, doi. 10.1111/bjh.18677
- By:
- Publication type:
- Article
Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 35, doi. 10.1111/bjh.18441
- By:
- Publication type:
- Article
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 5, p. 1004, doi. 10.1111/bjh.17423
- By:
- Publication type:
- Article
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
- By:
- Publication type:
- Article
Four‐year follow‐up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 404, doi. 10.1111/bjh.15411
- By:
- Publication type:
- Article
Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 561, doi. 10.1111/bjh.14669
- By:
- Publication type:
- Article
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 4, p. 561, doi. 10.1111/bjh.14731
- By:
- Publication type:
- Article
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 3, p. 382, doi. 10.1111/bjh.14061
- By:
- Publication type:
- Article
Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report.
- Published in:
- Journal of Oncology Pharmacy Practice, 2013, v. 19, n. 3, p. 261, doi. 10.1177/1078155212459285
- By:
- Publication type:
- Article
Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 890, doi. 10.1002/ajh.27281
- By:
- Publication type:
- Article
Safety and long‐term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single‐center phase 1,2 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 836, doi. 10.1002/ajh.27254
- By:
- Publication type:
- Article
Safety and efficacy of a new high‐dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high‐risk myeloma: Matched‐pair comparisons with concurrent control cohorts.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 245, doi. 10.1002/ajh.27168
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Chimeric antigen receptor T‐cell therapy toxicities.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 6, p. 2414, doi. 10.1111/bcp.14403
- By:
- Publication type:
- Article
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11712-6
- By:
- Publication type:
- Article
Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.
- Published in:
- European Journal of Haematology, 2017, v. 98, n. 3, p. 263, doi. 10.1111/ejh.12826
- By:
- Publication type:
- Article
Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy?
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 11, p. 1614, doi. 10.1007/s11864-022-01020-9
- By:
- Publication type:
- Article
P-197: Central nervous system Multiple Myeloma (CNS-MM), presentation and outcomes in an Era of anti-CD38 and pomalidomide inclusive therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S146, doi. 10.1016/S2152-2650(21)02324-7
- By:
- Publication type:
- Article
TCL-309: Prognostic Role of CD30 From a Retrospective Review of 295 Patients with Angioimmunoblastic T-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S414, doi. 10.1016/S2152-2650(21)01930-3
- By:
- Publication type:
- Article
Poster: TCL-309: Prognostic Role of CD30 From a Retrospective Review of 295 Patients with Angioimmunoblastic T-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01562-7
- By:
- Publication type:
- Article
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Depth of Response and Outcomes by Initial Therapy Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e298, doi. 10.1016/j.clml.2019.09.490
- By:
- Publication type:
- Article
Impact of cytogenetics versus FISH detected t(11;14) in newly diagnosed multiple myeloma patients with upfront transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e218, doi. 10.1016/j.clml.2019.09.363
- By:
- Publication type:
- Article
Impact of Health Care Insurance Status on Treatment Outcomes of Acute Myeloid Leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Detection of Harmful Chemical Compounds in Plastic Products Using a High‐Sensitivity Photonic Crystal‐Based Sensor.
- Published in:
- Physica Status Solidi. A: Applications & Materials Science, 2023, v. 220, n. 20, p. 1, doi. 10.1002/pssa.202300547
- By:
- Publication type:
- Article
An Efficient Photonic Crystal‐Based Chemical Sensor for the Detection of Isopropanol, Ethanol, and Acetone.
- Published in:
- Physica Status Solidi. A: Applications & Materials Science, 2023, v. 220, n. 7, p. 1, doi. 10.1002/pssa.202200811
- By:
- Publication type:
- Article
Haploidentical transplants for patients with relapse after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1187, doi. 10.1002/ajh.25924
- By:
- Publication type:
- Article
Haploidentical transplants for patients with graft failure after the first allograft.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E267, doi. 10.1002/ajh.25917
- By:
- Publication type:
- Article
Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. 1382, doi. 10.1002/ajh.25647
- By:
- Publication type:
- Article
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E442, doi. 10.1002/ajh.24487
- By:
- Publication type:
- Article
Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 12, p. 2291, doi. 10.1002/cncr.27989
- By:
- Publication type:
- Article
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2021, v. 144, n. 1, p. 74, doi. 10.1159/000507012
- By:
- Publication type:
- Article
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
- By:
- Publication type:
- Article
Molecular disparity of HLA‐DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 8, p. 1205, doi. 10.1002/cncr.34671
- By:
- Publication type:
- Article